Journal article
Annonacin exerts antitumor activity through induction of apoptosis and extracellular signal-regulated kinase inhibition
- Abstract:
-
Background: Endometrial cancer (EC) is the most common gynecologic malignancy in developed countries. Annonacin, a natural pure compound extracted from the seeds of Annona muricata, is a potential alternative therapeutic agent to treat EC.
Objective: To study the antitumor activity of annonacin and its mechanism of action in EC cells (ECCs).
Materials and Methods: Viability of ECCs treated with annonacin for 72 h was determined using methyl thiazolyl tetrazolium assay. The induction of cell cycle arrest and apoptotic cell death was evaluated using propidium iodide and annexin V-PE/7-AAD assay, respectively. DNA strand breaks were visualized using transferase dUTP nick end labeling assay, and the effects of annonacin on survival signaling were determined using western blotting.
Results: Annonacin exhibited antiproliferative effects on EC cell lines (ECC-1 and HEC-1A) and primary cells (EC6-ept and EC14-ept) with EC50values ranging from 4.62 to 4.92 μg/ml. EC cells were shown arrested at G2/M phase after treated with 4 μg/ml of annonacin for 72 h. This led to a significant increase in apoptotic cell death (65.7%) in these cells when compared to vehicle-treated cells (P < 0.005). We further showed that annonacin-mediated apoptotic cell death was associated with an increase in caspase-3 cleavage and DNA fragmentation. Cell apoptosis was accompanied with downregulation of extracellular signal-regulated kinase survival protein expression and induction of G2/M cell cycle arrest.
Conclusion: Annonacin may be a potential novel therapeutic agent for EC patients.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 3.7MB, Terms of use)
-
- Publisher copy:
- 10.4103/pr.pr_19_17
Authors
- Publisher:
- Medknow Publications
- Journal:
- Pharmacognosy Research More from this journal
- Volume:
- 9
- Issue:
- 4
- Pages:
- 378-383
- Publication date:
- 2017-11-16
- Acceptance date:
- 2017-04-26
- DOI:
- ISSN:
-
0976-4836
- Keywords:
- Pubs id:
-
pubs:747112
- UUID:
-
uuid:890377f3-1dc6-4a7e-8e1e-f9225007659a
- Local pid:
-
pubs:747112
- Source identifiers:
-
747112
- Deposit date:
-
2017-11-21
- ARK identifier:
Terms of use
- Copyright holder:
- Pharmacognosy Network Worldwide
- Copyright date:
- 2017
- Notes:
- © Pharmacognosy Network Worldwide. Open Access: available under a Creative Commons BY-NC-SA Licence.
If you are the owner of this record, you can report an update to it here: Report update to this record